The COVID-19 with CLD group showed an increased lymphocyte count as well as increased IL-6 and PCT levels, suggesting pathogenic effects from excessive inflammation in acute lung injury caused by COVID-19 infection. This evidence concerns the gene IL6 and COVID-19.